Catumaxomab
From Wikipedia, the free encyclopedia
|
Catumaxomab
|
|
|
|
|
| Source | Rat-murine hybrid |
| Target | EpCAM CD3 |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Catumaxomab is a rat-murine hybrid monoclonal antibody and which it's used to treat some cancers. It binds to andigen CD3.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Rat-murine hybrid monoclonal antibodies
Catumaxomab, Ertumaxomab
